Dataset:  -

approved

Приложение 4 на ПЛС от 02.07.2019 г.

Unique identificator:  78bb8ac6-d365-4ebe-8a53-ff25ecdcca67

Description:

Приложение 4 на ПЛС от 02.07.2019 г.

здравеопазване лекарства реимбурсиране

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-07-08 09:52:54
  • Created by: georgi_sivchev
  • Updated at: 2019-07-08 09:52:54
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Coagulation factor VIII (Moroctocog alfa) EU/1/99/103/006 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap Pfizer Europe MA EEIG, Белгия Wyeth Farma S.A, Испания 501.28 100.26 601.54 4% 10 511.28 102.26 613.54 16% 25 536.28 107.26 643.54 Промяна на обстоятелства НСР-17477/13.12.2018 НСР-7531/19.11.2015 05.12.2015 02.01.2019 Активен 3640
Coagulation factor VIII (Moroctocog alfa) EU/1/99/103/006 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap Pfizer Limited, Обединено Кралство Wyeth Farma S.A, Испания 501.28 100.26 601.54 4% 10 511.28 102.26 613.54 16% 25 536.28 107.26 643.54 НСР-7531/19.11.2015 05.12.2015 05.12.2015 Неактивен 3640
Coagulation factor VIII (Moroctocog alfa) EU/1/99/103/006 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap Pfizer Limited, Обединено Кралство Wyeth Farma S.A, Испания 501.28 100.26 601.54 4% 10 511.28 102.26 613.54 16% 25 536.28 107.26 643.54 НСР-7531/19.11.2015 05.12.2015 05.12.2015 Неактивен 3640
Coagulation factor VIII (Moroctocog alfa) EU/1/99/103/006 ReFacto AF, Powder and solvent for solution for injection, 500 IU, -, Pack: 1 pre filled syringe + 1 plunger rod + 1 sterile infusion set + 2 alcohol swabs + 1 plaster + 1 gauze + 1 vented sterile cap Pfizer Limited, Обединено Кралство Wyeth Farma S.A, Испания 501.28 100.26 601.54 4% 10 511.28 102.26 613.54 16% 25 536.28 107.26 643.54 НСР-7531/19.11.2015 05.12.2015 05.12.2015 Неактивен 3640
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/002 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Europe MA EEIG, Белгия Wyeth Farma S.A.. Autovia del Norte Испания 506.4 101.28 607.68 4% 10 516.4 103.28 619.68 16% 25 541.4 108.28 649.68 Промяна на обстоятелства НСР-17756/17.01.2019 НСР-7012/25.08.2015; НСР-11065/01.12.2016 г.; НСР-18103/07.03.2019 22.03.2019 02.04.2019 Активен 2453
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/002 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Europe MA EEIG, Белгия Wyeth Farma S.A.. Autovia del Norte Испания 508.5 101.7 610.2 4% 10 518.5 103.7 622.2 16% 25 543.5 108.7 652.2 Промяна на обстоятелства НСР-17756/17.01.2019 НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. 17.12.2016 02.02.2019 Неактивен 2453
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/002 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 508.5 101.7 610.2 4% 10 518.5 103.7 622.2 16% 25 543.5 108.7 652.2 НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. 17.12.2016 02.01.2017 Неактивен 2453
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/002 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 508.5 101.7 610.2 4% 10 518.5 103.7 622.2 16% 25 543.5 108.7 652.2 НСР-7012/25.08.2015; НСР-11065/01.12.2016 г. 17.12.2016 02.01.2017 Неактивен 2453
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/002 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 520.11 104.02 624.13 4% 10 530.11 106.02 636.13 16% 25 555.11 111.02 666.13 НСР-7012/25.08.2015 10.09.2015 10.09.2015 Неактивен 2453
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/002 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 520.11 104.02 624.13 4% 10 530.11 106.02 636.13 16% 25 555.11 111.02 666.13 НСР-7012/25.08.2015 10.09.2015 10.09.2015 Неактивен 2453
Coagulation factor VIII (Moroctocog alfa) EU/1/99/103/006 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A, Испания 520.11 104.02 624.13 4% 10 530.11 106.02 636.13 16% 25 555.11 111.02 666.13 НСР-5767/09.03.2015 23.03.2015 23.03.2015 Неактивен 3640
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/002 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 553.64 110.73 664.37 4% 10 563.64 112.73 676.37 16% 25 588.64 117.73 706.37 корекц. с Протокол 106/27.02.2015 НСР-2501/24.01.2014 12.02.2014 12.02.2014 Неактивен 2453
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/001-004 ReFacto AF, Powder and solvent for solution for injection, 1000, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 1107.23 221.45 1328.68 4% 10 1117.23 223.45 1340.68 16% 25 1142.23 228.45 1370.68 цената се заличава КЦРР-2536/14.03.2013 КЦРР-2039/21.01.2013 06.03.2013 06.03.2013 Заличен 1648
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/001-004 ReFacto AF, Powder and solvent for solution for injection, 250, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 280.09 56.02 336.11 4% 10 290.09 58.02 348.11 16% 25 315.09 63.02 378.11 КЦPP-1462/02.10.2012 промяна на обстоятелства; Цената е вписана в регистъра на пределните цени с решение НСР-3155/26.03.2014 КЦ-1970/26.01.2011 09.02.2011 09.02.2011 Заличен 1013
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/001-004 ReFacto AF, Powder and solvent for solution for injection, 1000, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 1120.4 224.08 1344.48 4% 10 1130.4 226.08 1356.48 16% 25 1155.4 231.08 1386.48 КЦ-1894/02.11.2010 16.11.2010 16.11.2010 Неактивен 1648
Coagulation factor VIII (Moroctocog alfa) ЕU/1/99/103/001-004 ReFacto AF, Powder and solvent for solution for injection, 500, IU, Pack: 1 Pfizer Limited, Обединено Кралство Wyeth Farma S.A.. Autovia del Norte Испания 560.21 112.04 672.25 4% 10 570.21 114.04 684.25 16% 25 595.21 119.04 714.25 КЦPP-1462/02.10.2012 промяна на обстоятелства КЦ-1894/02.11.2010 16.11.2010 16.11.2010 Неактивен 2453
Metoclopramide 20050444 Reglan, Tablet, 10, mg, Pack: 40 Алкалоид ЕООД, България Alkaloid-INT d.o.o. Slovenia 1.73 0.35 2.08 7% 0.12 1.85 0.37 2.22 20% 0.35 2.2 0.44 2.64 промяна на обстоятелства решение КЦPP-2325/20.02.2013 КЦ-221/19.09.2008; НСР-9684/30.06.2016 21.10.2008 02.08.2016 Заличен 98
Metoclopramide 15635/29.12.2006 г. Reglan, Tablet, 10, mg, Pack: 40 Алкалоид ЕООД, България Alkaloid-INT d.o.o. Slovenia 1.73 0.35 2.08 7% 0.12 1.85 0.37 2.22 20% 0.35 2.2 0.44 2.64 промяна на обстоятелства решение КЦPP-2325/20.02.2013 КЦ-221/19.09.2008 21.10.2008 21.10.2008 Неактивен 98
Metoclopramide 15634/29.12.2006 г. Reglan, Solution for injection, 10, mg, Pack: 30 Алкалоид ЕООД, България Алкалоид АД 4.84 0.97 5.81 9% 0.44 5.28 1.06 6.34 22% 1.06 6.34 1.27 7.61 Цената е заличена с решение КЦРР-391/29.03.2012 КЦ-221/19.09.2008 21.10.2008 21.10.2008 Заличен 99
Zanamivir 20010521 RELENZA, Inhalation powder, pre dispensed, 5 mg/dose x 4 doses x 5 rotadiskuses, -, Pack: 1 GlaxoSmithKline (Ireland) Limited, Ирландия Glaxo Wellcome Production, France 19.85 3.97 23.82 6% 1.19 21.04 4.21 25.25 18% 3.57 24.61 4.92 29.53 Прот. № 220/20.04.2017 г.; Промяна на обстоятелства НСР-18247/22.03.2019 НСР-4817/13.10.2014 27.10.2014 02.05.2019 Активен 3262
Zanamivir 20010521 RELENZA, Inhalation powder, pre dispensed, 5 mg/dose x 4 doses x 5 rotadiskuses, -, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France 19.85 3.97 23.82 6% 1.19 21.04 4.21 25.25 18% 3.57 24.61 4.92 29.53 Прот. № 220/20.04.2017 г. НСР-4817/13.10.2014 27.10.2014 02.05.2017 Неактивен 3262
Zanamivir 20010521 RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France 19.85 3.97 23.82 6% 1.19 21.04 4.21 25.25 18% 3.57 24.61 4.92 29.53 НСР-4817/13.10.2014 27.10.2014 27.10.2014 Неактивен 3262
Zanamivir 20010521 RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France 24.19 4.84 29.03 6% 1.45 25.64 5.13 30.77 18% 4.35 29.99 6 35.99 НСР-2539/24.01.2014 20.02.2014 20.02.2014 Неактивен 3262
Zanamivir 20010521 RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France 24.25 4.85 29.1 6% 1.46 25.71 5.14 30.85 18% 4.37 30.08 6.02 36.1 КЦРР-2779/20.03.2013 19.04.2013 19.04.2013 Неактивен 3262
Zanamivir 0805/10.10.2007 г. RELENZA, Inhalation powder, 5 mg/dose x 4 doses x 5 rotadiskuses, mg, Pack: 1 Glaxo Group Ltd., Обединено Кралство Glaxo Wellcome Production, France 24.43 4.89 29.32 6% 1.47 25.9 5.18 31.08 18% 4.4 30.3 6.06 36.36 КЦ-881/18.05.2009 01.06.2009 01.06.2009 Неактивен 3262
Showing 11001 to 11026 of 15076 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте